Shenzhen Bioeasy Valuation
| 300942 Stock | 8.48 0.50 5.57% |
At this time, the company appears to be overvalued. Shenzhen Bioeasy Bio has a current Real Value of USD6.91 per share. The regular price of the company is USD8.48. Our model measures the value of Shenzhen Bioeasy Bio from inspecting the company fundamentals such as Shares Outstanding of 400.87 M, operating margin of 0.02 %, and Return On Equity of -0.0919 as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 4.2301 | Enterprise Value 3.4 B | Enterprise Value Ebitda 29.3399 | Price Sales 13.7595 | Enterprise Value Revenue 13.9054 |
Overvalued
Today
Please note that Shenzhen Bioeasy's price fluctuation is slightly risky at this time. Calculation of the real value of Shenzhen Bioeasy Bio is based on 3 months time horizon. Increasing Shenzhen Bioeasy's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shenzhen Bioeasy is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shenzhen Stock. However, Shenzhen Bioeasy's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.48 | Real 6.91 | Hype 8.91 | Naive 8.74 |
The real value of Shenzhen Stock, also known as its intrinsic value, is the underlying worth of Shenzhen Bioeasy Bio Company, which is reflected in its stock price. It is based on Shenzhen Bioeasy's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shenzhen Bioeasy's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Shenzhen Bioeasy Biotechnology helps investors to forecast how Shenzhen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shenzhen Bioeasy more accurately as focusing exclusively on Shenzhen Bioeasy's fundamentals will not take into account other important factors: Shenzhen Bioeasy Cash |
|
Shenzhen Bioeasy Total Value Analysis
Shenzhen Bioeasy Biotechnology is presently forecasted to have takeover price of 3.44 B with market capitalization of 3.4 B, debt of 507.61 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shenzhen Bioeasy fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.44 B | 3.4 B | 507.61 M |
Shenzhen Bioeasy Investor Information
About 75.0% of the company shares are owned by insiders or employees . The book value of Shenzhen Bioeasy was presently reported as 2.13. The company recorded a loss per share of 0.2. Shenzhen Bioeasy Bio last dividend was issued on the 31st of May 2023. Based on the key measurements obtained from Shenzhen Bioeasy's financial statements, Shenzhen Bioeasy Biotechnology is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Shenzhen Bioeasy Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Shenzhen Bioeasy has an asset utilization ratio of 18.73 percent. This suggests that the Company is making USD0.19 for each dollar of assets. An increasing asset utilization means that Shenzhen Bioeasy Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Shenzhen Bioeasy Ownership Allocation
Shenzhen Bioeasy Bio shows a total of 400.87 Million outstanding shares. Shenzhen Bioeasy Bio has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.88 % of Shenzhen Bioeasy outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Shenzhen Bioeasy Profitability Analysis
The company reported the revenue of 254.11 M. Net Loss for the year was (184.91 M) with profit before overhead, payroll, taxes, and interest of 428.03 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Shenzhen Bioeasy's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Shenzhen Bioeasy and how it compares across the competition.
About Shenzhen Bioeasy Valuation
The stock valuation mechanism determines Shenzhen Bioeasy's current worth on a weekly basis. Our valuation model uses a comparative analysis of Shenzhen Bioeasy. We calculate exposure to Shenzhen Bioeasy's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shenzhen Bioeasy's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 126.9 M | 242 M |
Shenzhen Bioeasy Quarterly Retained Earnings |
|
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Bioeasy's price analysis, check to measure Shenzhen Bioeasy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Bioeasy is operating at the current time. Most of Shenzhen Bioeasy's value examination focuses on studying past and present price action to predict the probability of Shenzhen Bioeasy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Bioeasy's price. Additionally, you may evaluate how the addition of Shenzhen Bioeasy to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |